Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation? - Aix-Marseille Université Access content directly
Journal Articles Cells Year : 2018

Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation?

Abstract

Lung cancer represents the primary cause of cancer death in the world. Malignant cells identification and characterization are crucial for the diagnosis and management of patients with primary or metastatic cancers. In this context, the identification of new biomarkers is essential to improve the differential diagnosis between cancer subtypes, to select the most appropriate therapy, and to establish prognostic correlations. Nuclear abnormalities are hallmarks of carcinoma cells and are used as cytological diagnostic criteria of malignancy. Lamins (divided into A- and B-types) are localized in the nuclear matrix comprising nuclear lamina, where they act as scaffolding protein, involved in many nuclear functions, with regulatory effects on the cell cycle and differentiation, senescence and apoptosis. Previous studies have suggested that lamins are involved in tumor development and progression with opposite results concerning their prognostic role. This review provides an overview of lamins expression in lung cancer and the relevance of these findings for disease diagnosis and prognosis. Furthermore, we discuss the link between A-type lamins expression in lung carcinoma cells and nuclear deformability, epithelial to mesenchymal transition, and metastatic potential, and which mechanisms could regulate A-type lamins expression in lung cancer, such as the microRNA miR-9.

Domains

Human genetics
Fichier principal
Vignette du fichier
cells-dépotHAL.pdf (636.27 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01991352 , version 1 (23-02-2023)

Licence

Attribution

Identifiers

Cite

Julien Guinde, Diane Frankel, Sophie Perrin, Valerie Delecourt, Nicolas Levy, et al.. Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation?. Cells, 2018, 7 (7), ⟨10.3390/cells7070078⟩. ⟨hal-01991352⟩
143 View
11 Download

Altmetric

Share

Gmail Facebook X LinkedIn More